Correlation Between InMode and Recursion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both InMode and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMode and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InMode and Recursion Pharmaceuticals, you can compare the effects of market volatilities on InMode and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMode with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMode and Recursion Pharmaceuticals.

Diversification Opportunities for InMode and Recursion Pharmaceuticals

0.25

Correlation Coefficient

InMode  Recursion Pharmaceuticals

Modest diversification

The 3 months correlation between InMode and Recursion is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding InMode and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and InMode is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMode are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of InMode i.e., InMode and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between InMode and Recursion Pharmaceuticals

Given the investment horizon of 90 days InMode is expected to generate 0.33 times more return on investment than Recursion Pharmaceuticals. However, InMode is 3.0 times less risky than Recursion Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  1,663  in InMode on December 29, 2024 and sell it today you would earn a total of  167.00  from holding InMode or generate 10.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

InMode  vs.  Recursion Pharmaceuticals

InMode

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in InMode are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, InMode may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Recursion Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Recursion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Recursion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with InMode and Recursion Pharmaceuticals

The main advantage of trading using opposite InMode and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMode position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.

The idea behind InMode and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.